Paresis: Clinical Trials

7 trials for Paresis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 3 unknown, 1 recruiting. 7 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 37Completed 3, Unknown 3, Recruiting 1
Phase 23Completed 1, Recruiting 1, Unknown 1

Follow Paresis: new trials by email Literature Review of Paresis trials Research Report on Paresis

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Wereables for Upper Limb Functionality in Hemiparesis
WeFun-wearable activated, WeFun-wearable desactivated - Unilateral Cerebral Palsy
Phase 2 / Phase 3RecruitingUniversidade da Coruña402024-06-072025-03-12
Efficacy of Extracorporeal Shock Wave Therapy in Children With Cerebral Palsy
ESWT, Botulinum Toxin Type A, Serial Casting - Spasticity/Paresis, Cerebral Palsy
Phase 3UnknownKocaeli University402023-11-012023-11-18
Perinatal Arterial Stroke: A Multi-site RCT of Intensive Infant Rehabilitation (I-ACQUIRE)
I-ACQUIRE - High Dosage, I-ACQUIRE - Moderate Dosage, Usual & Customary Treatment (U&CT) - Perinatal Stroke, Hemiparesis
Phase 3CompletedVirginia Polytechnic Institute and State University2162019-10-102026-06-01
Burke-Hocoma Efficiency Study
Hocoma ArmeoSpring - Hemiparesis, Hemiplegia
Phase 3CompletedBurke Medical Research Institute472016-05-012022-10-04
Functional Recovery in Stroke Patients With Task-Specific Robot-Aided Arm Therapy
robot therapy (ARMin), conventional therapy - Stroke, Upper Extremity Paresis
Phase 2 / Phase 3CompletedUniversity of Zurich762008-07-012013-04-22
Safety and Effectiveness of Cortical Stimulation in the Treatment of Stroke Patients With Upper Extremity Hemiparesis
Cortical Stimulation and rehabilitation, Rehabilitation - Stroke, Hemiparesis
Phase 3UnknownNorthstar Neuroscience1742004-09-012007-12-28
Efficacy of Tacrolimus and I.V.-Immunoglobulins in Rasmussen Encephalitis
Tacrolimus, i.v. immunoglobulins - Rasmussen Encephalitis
Phase 2 / Phase 3UnknownUniversity Hospital, Bonn162002-11-012009-04-10

Narrower conditions

Cerebral Palsy (3)  ·  Stroke (2)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Encephalitis (1)  ·  Epilepsy (1)  ·  Fatigue (1)  ·  Hemiplegia (1)  ·  Ischemic Stroke (1)  ·  Motor Activity (1)  ·  Muscle Spasticity (1)

Broader conditions

Nervous System Diseases (7)  ·  Neurologic Manifestations (7)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Signs and Symptoms (7)  ·  Brain Diseases (6)  ·  Central Nervous System Diseases (6)  ·  Brain Damage, Chronic (3)  ·  Cardiovascular Diseases (2)  ·  Cerebrovascular Disorders (2)  ·  Vascular Diseases (2)  ·  Behavior (1)  ·  Bronchial Diseases (1)  ·  Bronchiolitis (1)  ·  Bronchiolitis Obliterans (1)  ·  Bronchitis (1)

Interventions

Botulinum Toxins, Type A (1)  ·  Occupational Therapy (1)  ·  Octagam (1)  ·  Physical Therapy Modalities (1)  ·  Rehabilitation (1)  ·  Tacrolimus (1)

Sponsors

Burke Medical Research Institute (1)  ·  Kocaeli University (1)  ·  Northstar Neuroscience (1)  ·  Universidade da Coruña (1)  ·  University Hospital, Bonn (1)  ·  University of Zurich (1)  ·  Virginia Polytechnic Institute and State University (1)

Countries

United States (3)  ·  Germany (1)  ·  Spain (1)  ·  Switzerland (1)

Top investigators

Armin Curt, Prof. (1)  ·  Christian G Bien, M.D. (1)  ·  Nigar Dursun, MD (1)  ·  Robert Riener, Prof. (1)  ·  Sharon L Ramey, Ph.D. (1)  ·  Tomoko Kitago, MD (1)  ·  Warren Lo, M.D. (1)

Results publications

PMID 24382580, PMID 25748452, PMID 26812925, PMID 27631386, PMID 27724916, PMID 31691605, PMID 32250331, PMID 33206382, PMID 33483965, PMID 34828772, PMID 35412036, PMID 36306168, PMID 36832460, PMID 42852504